LUMRYZ®

(sodium oxybate for extended-release oral suspension)

Prescribing Information Medication Guide Instructions for Use
Publications

Studies designed, executed, and funded by an Alkermes company.

Aug 2021
Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy
Sleep
AUTHOR(S)

Kushida CA, Shaprio CM, Roth T, Thorpy MJ, Corser BC, Ajayi AO, Rosenberg R, Roy A, Seiden D, Dubow J, Dauvilliers Y

View on PubMed
Clinical
Sleep-wake disorders
Mar 2024
Cataplexy response with extended-release once-nightly sodium oxybate: Post hoc responder analyses from the phase 3 REST-ON clinical trial
Sleep Medicine: X
AUTHOR(S)

Thorpy MJ, Kushida CA, Bogan R, Ajayi AO, Corser BC, Gudeman J

View on PubMed
Clinical
Sleep-wake disorders
May 2024
Improvement in sleep latency with extended-release once-nightly sodium oxybate for the treatment of adults with narcolepsy: Analysis from the phase 3 REST-ON clinical trial
Sleep Medicine: X
AUTHOR(S)

Thorpy MJ, Kushida CA, Bogan R, Winkelman J, Ohayon MM, Shapiro CM, Gudeman J

View on PubMed
Clinical
Sleep-wake disorders